Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Aardvark Therapeutics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.77 | -$0.57 | -$0.67 |
| Q2 2025 | 2 | -$0.68 | -$0.52 | -$0.60 |
| Q3 2025 | 2 | -$0.81 | -$0.70 | -$0.76 |
| Q4 2025 | 2 | -$0.85 | -$0.77 | -$0.81 |
| Q1 2026 | 1 | -$0.83 | -$0.83 | -$0.83 |
| Q2 2026 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q3 2026 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q4 2026 | 1 | -$0.96 | -$0.96 | -$0.96 |
Aardvark Therapeutics, Inc. Common Stock Earnings Date And Information
Aardvark Therapeutics, Inc. Common Stock last posted its earnings results on Wednesday, August 13th, 2025. The company reported $-0.66 earnings per share for the quarter, missing analysts' consensus estimates of $-0.52 by $0.14. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Aardvark Therapeutics, Inc. Common Stock has generated $-2 earnings per share over the last year ($-1.59 diluted earnings per share) and currently has a price-to-earnings ratio of -5.64. Aardvark Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based on prior year's report dates.
Aardvark Therapeutics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2025 | Q2 2025 | -$0.52 | -$0.66 | -0.14 | $0 | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$0.71 | N/A | $0 | $0 |
| 03/31/2025 | Q4 2024 | N/A | -$0.68 | N/A | $0 | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.32 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$2.13 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.17 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.21 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$0.22 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aardvark Therapeutics, Inc. Common Stock Earnings: FAQ's
Aardvark Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based offlast year's report dates.
The conference call for Aardvark Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
The conference call transcript for Aardvark Therapeutics, Inc. Common Stock's latest earnings report can be read online.
Aardvark Therapeutics, Inc. Common Stock (:AARD) has a recorded net income of $-20,588,000.Aardvark Therapeutics, Inc. Common Stock has generated $-1.59 earnings per share over the last four quarters.
Aardvark Therapeutics, Inc. Common Stock (:AARD) has a price-to-earnings ratio of -5.64 and price/earnings-to-growth ratio is -0.15.